Home » Topics » Briefs » Other news to note

Other news to note
RSS

MiddleBrook Pharmaceuticals completes sale of assets to Victory Pharma

Aug. 4, 2010

Pharmachem Laboratories offers to acquire all assets from Forbes Medi-Tech

Aug. 4, 2010

Lexicon reacquires rights to several serotonin synthesis inhibitors from Symphony Icon

Aug. 4, 2010

FDA approves Xeomin for cervical dystonia and blepharospasm

Aug. 3, 2010

Conatus Pharmaceuticals acquires Idun Pharmaceuticals from Pfizer

Aug. 3, 2010

Curaxis Pharmaceutical merges with Auto Search Cars

Aug. 2, 2010

Novartis begins phase I trial of HuCAL-derived antibody

Aug. 2, 2010

Actient Pharmaceuticals acquires six pharmaceuticals from UCB

Aug. 2, 2010

Daiichi Sankyo and Kitasato Institute to form joint venture company

Aug. 2, 2010

Charles River Laboratories and WuXi PharmaTech terminate acquisition agreement

Aug. 2, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...